logo
#

Latest news with #PJP

Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

Yahoo

timea day ago

  • Business
  • Yahoo

Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund launched on June 23, 2005. Retail and institutional investors increasingly turn to passively managed ETFs because they offer low costs, transparency, flexibility, and tax efficiency; these kind of funds are also excellent vehicles for long term investors. Invest in Gold Thor Metals Group: Best Overall Gold IRA Priority Gold: Up to $15k in Free Silver + Zero Account Fees on Qualifying Purchase American Hartford Gold: #1 Precious Metals Dealer in the Nation Sector ETFs are also funds of convenience, offering many ways to gain low risk and diversified exposure to a broad group of companies in particular sectors. Healthcare - Pharma is one of the 16 broad Zacks sectors within the Zacks Industry classification. It is currently ranked 6, placing it in top 38%. Index Details The fund is sponsored by Invesco. It has amassed assets over $257.58 million, making it one of the average sized ETFs attempting to match the performance of the Healthcare - Pharma segment of the equity market. PJP seeks to match the performance of the Dynamic Pharmaceutical Intellidex Index before fees and expenses. The Dynamic Pharmaceutical Intellidex Index is comprised of stocks of U.S. pharmaceutical companies. It is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. Costs Cost is an important factor in selecting the right ETF, and cheaper funds can significantly outperform their more expensive counterparts if all other fundamentals are the same. Annual operating expenses for this ETF are 0.56%, making it on par with most peer products in the space. It has a 12-month trailing dividend yield of 1.07%. Sector Exposure and Top Holdings It is important to delve into an ETF's holdings before investing despite the many upsides to these kinds of funds like diversified exposure, which minimizes single stock risk. And, most ETFs are very transparent products that disclose their holdings on a daily basis. This ETF has heaviest allocation in the Healthcare sector -- about 100% of the portfolio. Looking at individual holdings, Eli Lilly & Co (LLY) accounts for about 5.24% of total assets, followed by Pfizer Inc (PFE) and Amgen Inc (AMGN). The top 10 holdings account for about 47.34% of total assets under management. Performance and Risk Year-to-date, the Invesco Pharmaceuticals ETF has added roughly 9.35% so far, and was up about 6.41% over the last 12 months (as of 08/19/2025). PJP has traded between $74.593 and $90.012 in this past 52-week period. The ETF has a beta of 0.48 and standard deviation of 15.82% for the trailing three-year period, making it a high risk choice in the space. With about 32 holdings, it has more concentrated exposure than peers. Alternatives Invesco Pharmaceuticals ETF carries a Zacks ETF Rank of 3 (Hold), which is based on expected asset class return, expense ratio, and momentum, among other factors. Thus, PJP is a sufficient option for those seeking exposure to the Health Care ETFs area of the market. Investors might also want to consider some other ETF options in the space. VanEck Pharmaceutical ETF (PPH) tracks MVIS US Listed Pharmaceutical 25 Index and the iShares U.S. Pharmaceuticals ETF (IHE) tracks Dow Jones U.S. Select Pharmaceuticals Index. VanEck Pharmaceutical ETF has $532.51 million in assets, iShares U.S. Pharmaceuticals ETF has $571.47 million. PPH has an expense ratio of 0.36%, and IHE charges 0.39%. Bottom Line To learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Invesco Pharmaceuticals ETF (PJP): ETF Research Reports This article originally published on Zacks Investment Research ( Zacks Investment Research

PJP Dam Nears Full Capacity Amid Heavy Inflows; Spillway Gates Open to Regulate Outflow
PJP Dam Nears Full Capacity Amid Heavy Inflows; Spillway Gates Open to Regulate Outflow

Hans India

time29-06-2025

  • Business
  • Hans India

PJP Dam Nears Full Capacity Amid Heavy Inflows; Spillway Gates Open to Regulate Outflow

Gadwal: The Priyadarshini Jurala Project (PJP) on the Krishna River continues to receive significant inflows due to upstream rains and catchment contributions, with the water level nearing its Full Reservoir Level (FRL). As of 6:00 PM on 29th June 2025, the water level stood at 317.300 meters (1,041.010 feet), just 1.216 meters below its FRL of 318.516 meters, which corresponds to a gross storage capacity of 9.657 TMC. Current Storage Status: Gross Storage: 7.279 TMC Live Storage: 3.572 TMC Full Reservoir Level (FRL): 318.516 meters Current Water Level: 317.300 meters This level indicates that the reservoir is holding a substantial volume of water, boosting both irrigation prospects and power generation potential in the region. Inflow and Outflow Situation: The project has been receiving an inflow of 1.5 lakh cusecs, mainly due to upstream releases and monsoon runoff. To manage the rising water levels, 12 spillway gates have been opened, releasing a discharge of 1,16,424 cusecs downstream. Additionally, power generation operations are underway, with 25,785 cusecs being utilized by the powerhouse turbines. Water Utilization and Drawals: Various lift irrigation schemes and canal systems are drawing water to meet agricultural and regional requirements: Bhima Lift-I Scheme: 650 cusecs Koilsagar Lift Scheme: 315 cusecs Left Main Canal (LMC): 150 cusecs Right Main Canal (RMC): 290 cusecs (Includes RDS Link Canal contribution of 150 cusecs) Notably, the Nettampadu Lift, Bhima Lift-II, and Parallel Canal have reported no drawals as of the time of reporting. Evaporation losses were recorded at 42 cusecs, a typical figure under prevailing climatic conditions. Total Outflow: Cumulatively, the total outflow from the reservoir (including spillway, canals, lifts, power generation, and evaporation) stood at 1,43,656 cusecs. Implications and Outlook: With the dam approaching full capacity and inflows still substantial, dam authorities are maintaining a cautious approach by regulating spillway discharges. Farmers in the command areas of the Left and Right Canals are expected to benefit from the assured irrigation supply in the upcoming Kharif season. However, officials remain vigilant about potential increases in inflow and are coordinating with downstream reservoirs and local administrations for precautionary measures. No flood warnings have been issued so far, but villages along the Krishna basin are advised to stay informed through official channels. This active water management demonstrates the preparedness of the irrigation and water resources department to handle monsoon inflows efficiently, ensuring both safety and utility optimization.

PJP Dam Nears Full Capacity with Heavy Inflows; Authorities Regulate Outflows to Maintain Safety
PJP Dam Nears Full Capacity with Heavy Inflows; Authorities Regulate Outflows to Maintain Safety

Hans India

time26-06-2025

  • General
  • Hans India

PJP Dam Nears Full Capacity with Heavy Inflows; Authorities Regulate Outflows to Maintain Safety

Gadwal: The Priyadarshini Jurala Project (PJP) dam, a critical irrigation and power generation structure on the Krishna River, recorded a substantial surge in inflows and regulated outflows as of 6:00 PM on June 26, 2025. With the onset of early monsoon showers in the upstream regions, water levels have risen significantly, prompting coordinated management of the reservoir through controlled spillway discharge and lift irrigation operations. Current Reservoir Status: Water Level: 317.360 meters (1,041.207 feet) Full Reservoir Level (FRL): 318.516 meters (1,045 feet) Gross Storage Capacity: 7.389 TMC Live Storage (usable): 3.682 TMC Maximum Gross Capacity (at FRL): 9.657 TMC The water level has approached near capacity, standing just 1.156 meters below the Full Reservoir Level. With 3.682 TMC of live storage, the dam has sufficient reserves to meet both irrigation and power demands over the short term. Inflows and Outflows: Inflow: 98,000 cusecs Total Outflow: 1,03,307 cusecs Due to substantial inflows from upstream catchment areas, the dam management has initiated major outflow operations to ensure reservoir safety and balance. Break-up of Outflows: Spillway Discharge: 73,998 cusecs (via 12 gates) Power House Discharge: 27,461 cusecs Lift Irrigation & Canal Drawals: Bhima Lift-I: 650 cusecs Koilsagar Lift: 315 cusecs Left Main Canal (LMC): 550 cusecs Right Main Canal (RMC): 290 cusecs RDS Link Canal: 150 cusecs Parallel Canal & Bhima Lift-II: Nil Evaporation Loss: 43 cusecs Nettampadu Lift: Nil Other Drawals: Nil The current outflow exceeds the inflow marginally by about 5,307 cusecs, which may indicate proactive water level control measures by dam authorities to prepare for potential further inflow surges. Operational Observations: The spillway gates have been actively used to release excess water, signaling a precautionary flood regulation mechanism. The powerhouse continues to discharge over 27,000 cusecs, contributing to electricity generation while helping manage reservoir levels. The Bhima and Koilsagar lift irrigation schemes are drawing moderate volumes, indicating active use of water for irrigation, although Nettampadu and Bhima-II lifts remain idle, likely due to operational or demand-related reasons. Water is being channeled through the Left and Right Main Canals and the RDS Link Canal, ensuring supply to agricultural zones downstream. Safety and Management Outlook: With the monsoon intensifying, dam authorities are maintaining vigilant oversight. Engineers are carefully balancing inflows and outflows to protect structural integrity and avoid downstream flooding. Farmers and residents along the riverbanks and canal networks are advised to remain alert and follow any updates issued by irrigation and disaster management departments. Conclusion: The current status of the PJP Dam reflects healthy reservoir levels with robust water management in place. While the situation is under control, authorities are likely to adjust gate operations in line with weather forecasts and further upstream inflows. Continued monitoring and timely communication with downstream stakeholders remain essential to ensure safety and optimal water usage.

Kadu Ends Hunger Strike After State Govt Assurance
Kadu Ends Hunger Strike After State Govt Assurance

Time of India

time14-06-2025

  • Politics
  • Time of India

Kadu Ends Hunger Strike After State Govt Assurance

Nagpur/Amravati: Prahar Janshakti Party (PJP) president Bachchu Kadu on Saturday ended his week-long hunger strike at Gurukunj Mozari in Amravati after receiving a written assurance from the Maharashtra govt regarding his key demands. Industries Minister Uday Samant handed Kadu an official letter from revenue minister Chandrashekhar Bawankule, confirming the state's commitment to address the issues in a time-bound manner. Kadu, who was on hunger strike since Sunday last, was demanding the implementation of 17 key demands, most prominently a blanket farm loan waiver, issuance of fresh agricultural loans ahead of the kharif season, and an increase in the monthly honorarium to persons with disabilities (divyangs). According to the letter from Bawankule, the govt agreed to constitute a high-powered committee within 15 days to finalise the mechanism for the farm loan waiver. A formal decision on the waiver will follow the committee's report. It also states that the govt will hold a separate meeting to decide on stopping the forcible recovery of pending farm loans and facilitating the disbursal of new crop loans. Regarding the hike in the monthly honorarium for divyangs, the letter notes that a budgetary provision for this will be included in the supplementary demands scheduled for the monsoon session of the legislature beginning June 30. For the remaining demands, the govt assured further meetings with concerned ministers and the chief minister. K adu ended his agitation after recieving the letter, breaking his fast by accepting juice from Samant. Later, both leaders paid tribute to Rashtrasant Tukadoji Maharaj at Mozari. MLA Amol Mitkari and senior leader Kamaltai Gawai were also present. Kadu also spoke with CM Devendra Fadnavis on the phone. Samant expressed gratitude to Kadu for responding positively to the state's appeal. "The govt has taken his demands seriously. His health deteriorated over the past few days, and we are relieved that he has ended his fast," he said. Kadu, while thanking supporters, warned that if the promises made are not implemented, he along with supporters will march into Mumbai's Mantralaya on Oct 2. "This is only a pause. If the govt does not act, we will return with stronger resolve," he said. The protest, which drew wide political attention and backing from opposition parties including the Congress, was aimed at pressing for unconditional farm loan waivers and urgent relief measures for affected communities. Congress Legislature Party leader Vijay Wadettiwar earlier expressed solidarity with Kadu, urging the govt to act instead of issuing fresh assurances. "If the govt is serious, it must act, not delay further," Wadettiwar said. Follow more information on Air India plane crash in Ahmedabad here . Get real-time live updates on rescue operations and check full list of passengers onboard AI 171 .

Terrifying rise of fungal infection sweeping US
Terrifying rise of fungal infection sweeping US

Daily Mail​

time04-06-2025

  • Health
  • Daily Mail​

Terrifying rise of fungal infection sweeping US

The killer fungi that led to the tragic death of Hollywood stylist Jesus Guerrero is exploding among people who previously have not been at risk. Guerrero, known for working with stars like Kylie Jenner and Jennifer Lopez, died at a Los Angeles hospital in February. The medical examiner confirmed the celebrity stylist died from two deadly fungal infections: Pneumocystis jirovecii pneumonia (PJP) and Cryptococcus neoformans, most likely a complication of AIDS, which was listed as a secondary cause of death. It is not known how he became infected. People with HIV or AIDS historically represent the largest population affected by the fungi, because of their weakened immune systems. However, cases are now alarmingly rising among broader populations, including non HIV or AIDS-immunosuppressed patients. North-American cryptococcal cases have jumped 62 percent since 2014, while UK Pneumocystis infections doubled. Aside from those battling HIV, these infections can more easily strike other people with weakened immunity, including patients undergoing cancer treatments, those who are on immunosuppressants after an organ transplant - and even those with a Covid infection. 'These individuals might not be on doctors' radar for infections like PJP, so they often aren't given preventive treatments the way HIV-positive patients are,' Dr Ehsan Ali, an internal medicine specialist. 'That delay in recognition and care can be life-threatening. The killer fungi that led to the death of Hollywood stylist Jesus Guerrero is exploding among people who previously have not been at risk Guerro, pictured with one of his former clients Kylie Jenner, succumbed to Pneumocystis jirovecii pneumonia (PJP) and Cryptococcus neoformans, two fungal infections which are on the rise He likely developed the infections due to being HIV positive as AIDS was listed a secondary cause of death, however doctors are warning the infections are reaching other immunocompromised patients who don't have HIV or AIDS 'The growing number of non-HIV patients developing these infections is a sign that we need to rethink how we monitor and protect people with suppressed immune systems. 'Just because someone doesn't have HIV doesn't mean they're not at risk, and catching these infections early can be the difference between recovery and tragedy.' Pneumocystis jirovecii is a silent airborne killer whose spores float undetected. It attacks the lungs with deadly inflammation that drowns victims in fluid and deprives the body of oxygen, leading to multi-organ failure. Cryptococcus, meanwhile, hides in soil and bird droppings, invading lungs before migrating to the brain to cause fatal meningitis. There it unleashes a double onslaught of meningitis and encephalitis - brain swelling - often with fatal consequences. A trio of telltale signs of PJP – a dry cough (95 percent of patients), trouble breathing, and a low-grade fever (around 80 percent) – is a key indication of the fungal infection in the lungs. Since its discovery in the 1980s, PJP has been considered a disease solely of the immunocompromised, particularly in people suffering from AIDS. While typically believed to be a condition associated with HIV/AIDS, Dr Ali said patients undergoing chemotherapy, recovering from organ transplants, or taking medications like steroids or immunosuppressants for conditions like lupus, rheumatoid arthritis, or Crohn's disease, represent a growing patient population. In 2005, three-year-old Eliza Jane [center] died from pneumocystis pneumonia caused by the fungus Pneumocystis jirovecii Eliza Jane began vomiting and within hours, she collapsed. Tests revealed a severe case of pneumonia that had advanced past the ability to treat. Eliza Jane died the next day. In 2005, three-year-old Eliza Jane Scovill, who later tested HIV-positive, died from a pneumonia caused by Pneumocystis jirovecii. Eliza Jane was born to a mother with HIV who denied the virus caused AIDS and so did not test her daughter for the condition. This which severely weakened the little girl's immune system and left her susceptible to infection. The youngster had been suffering from common cold symptoms and collapsed on May 15, 2005. She died the next day and an autopsy revealed she'd had pneumonia for weeks. But PJP has been shown to be even deadlier in non-HIV-positive patients with weakened immune systems. Global death rates in people with weakened immune systems but without HIV range from 30 to 60 percent, compared to 10 to 20 percent of HIV patients. Meanwhile, the global mortality rate of Cryptococcus neoformans infection is high in people with HIV – roughly 41 to 61 percent — and the early warning signs can be easy to miss. Doctors say it typically starts out with headaches, fever, cough, and shortness of breath. As it spreads, it can cause stiff neck, nausea, confusion, and sensitivity to light — signs the infection has reached the brain and triggered life-threatening meningitis. Cryptococcus hides in soil and bird droppings, invading lungs before migrating to the brain to cause fatal meningitis Your browser does not support iframes. Around 19 percent of AIDS-related deaths are due to meningitis caused by Cryptococcus neoformans. Scientists are still trying to pinpoint the exact cause of the rising rates of fungal infections. The number of people with weakened immune systems is on the rise as rates of chronic illness and disease increase. Cancer rates and people being treated for the disease are steadily ticking up, translating to a growing population of immunocompromised people. Climate change also has a major role to play - with rising global temperatures potentially forcing fungi to grow in places it previously hasn't or evolve to become more adaptable and resistant to treatments. Robin May, a professor of infectious diseases at the University of Birmingham in England, said: 'Since we have far fewer drugs against fungi than we do against bacteria, the antifungal arsenal is very limited, and resistance to only one or two drugs can render a fungus essentially untreatable.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store